Napo Drug Patent Portfolio
Napo owns 1 orange book drug protected by 5 US patents Given below is the list of Napo's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8962680 | Methods and compositions for treating HIV-associated diarrhea | 31 Oct, 2031 | Active |
| US9585868 | Methods and compositions for treating HIV-associated diarrhea | 31 Oct, 2031 | Active |
| US7341744 | Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer | 16 Jun, 2018 | Expired |
| US7323195 | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions | 07 Jun, 2018 | Expired |
| US8574634 | Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions | 11 Jan, 2018 | Expired |
Latest Legal Activities on Napo's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Napo.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Expire Patent
Critical
| 13 Dec, 2021 | US8574634 |
|
Maintenance Fee Reminder Mailed
Critical
| 28 Jun, 2021 | US8574634 |
| Payment of Maintenance Fee, 4th Yr, Small Entity | 31 Aug, 2020 | US9585868 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 01 Jul, 2020 | US9585868 |
|
Email Notification
Critical
| 01 Jul, 2020 | US9585868 |
|
Correspondence Address Change
Critical
| 29 Jun, 2020 | US9585868 |
|
Correspondence Address Change
Critical
| 29 Jun, 2020 | US8574634 |
|
Expire Patent
Critical
| 02 Mar, 2020 | US7323195 |
|
Maintenance Fee Reminder Mailed
Critical
| 16 Sep, 2019 | US7323195 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 07 Mar, 2017 | US9585868 |
|
Recordation of Patent Grant Mailed
Critical
| 07 Mar, 2017 | US9585868 |
|
Email Notification
Critical
| 16 Feb, 2017 | US9585868 |
|
Issue Notification Mailed
Critical
| 15 Feb, 2017 | US9585868 |
|
Application Is Considered Ready for Issue
Critical
| 31 Jan, 2017 | US9585868 |
| Dispatch to FDC | 31 Jan, 2017 | US9585868 |
Napo's Family Patents
Napo Drug List
Given below is the complete list of Napo's drugs and the patents protecting them.
1. Mytesi
Mytesi is protected by 5 patents, out of which 3 have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8962680 | Methods and compositions for treating HIV-associated diarrhea |
31 Oct, 2031
(5 years from now)
| Active |
| US9585868 | Methods and compositions for treating HIV-associated diarrhea |
31 Oct, 2031
(5 years from now)
| Active |
| US7341744 | Method of treating secretory diarrhea with enteric formulations of proanthocyanidin polymer |
16 Jun, 2018
(7 years ago)
| Expired |
| US7323195 | Enteric formulations of proanthocyanidin polymer antidiarrheal compositions |
07 Jun, 2018
(7 years ago)
| Expired |
| US8574634 | Compositions and methods of treatment with proanthocyanidin polymer antidiarrheal compositions |
11 Jan, 2018
(7 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Mytesi's drug page